Waters Corporation  today announced the launch of the BioResolvetm Protein A Affinity Columns with MaxPeaktm Premier Technology, providing precise titer measurements. This launch marks the first set ...

CDR-Life today announced the appointment of Pascal Touchon, DVM, MBA, to its Board of Directors. Dr. Touchon brings 40 years of international experience in the biopharmaceutical industry, with ...

The timeline of nanobody development reflects a steady series of innovations. In 2001, the term "nanobody" was introduced by ...

New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 76.5 billion (approximately ...

The PACC5, CDR-sb, and ADCS activities of daily living will measure ... One attendee asked if using two antibodies might overtax microglia. Reyderman said she didn’t anticipate the two to be additive ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

Innovative antibody drug conjugates are advancing in ovarian cancer treatment, exploring new maintenance therapies and ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...

Engineering an antibody against flu with sticky staying power Aerosol treatment adheres to lung lining, blocks infection in mice Date: May 8, 2025 Source: Ohio State University Summary: Scientists ...